ghk-cu hair growth human trial ghk-cu hair growth clinical trial
Description
ClinicalTrials.gov identifier: NCT05669781
Check out the infographic to learn some facts about HCG injections during pregnancy
Neuro Endocrinology Letters , 23 (4), 365368
No treatment-related serious adverse events occurred, and no study withdrawals were due to adverse events attributable to the peptide
Chemical & Handling Information Type: Synthetic FOXO4-interacting peptide analog Peptide length: Short peptide (exact sequence per specification/lot) Appearance: White to off-white lyophilized powder Specifications Peptide: FOXO4-DRI Amount: 5 mg per vial Form: Lyophilized powder Purity: ?99% (HPLC)
